Justin Guild
22Patents
14h-index
15Co-inventors
70Inventor score
Filing activity: Mar 9, 2013 → Sep 20, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8999380B2 | Modified polynucleotides for the production of biologics and proteins associated with human disease | Emerging Cross-Sectional Technologies | 177 | Active |
| US9254311B2 | Modified polynucleotides for the production of proteins | Chemistry; Metallurgy | 100 | Active |
| US9221891B2 | In vivo production of proteins | Chemistry; Metallurgy | 98 | Active |
| US9572896B2 | In vivo production of proteins | Chemistry; Metallurgy | 65 | Active |
| US9587003B2 | Modified polynucleotides for the production of oncology-related proteins and peptides | Chemistry; Metallurgy | 59 | Active |
| US9572897B2 | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins | Chemistry; Metallurgy | 52 | Active |
| US9504734B2 | Modified polynucleotides for the production of nuclear proteins | Chemistry; Metallurgy | 50 | Active |
| US10323076B2 | Polynucleotides encoding low density lipoprotein receptor | Human Necessities | 45 | Active |
| US10577403B2 | Modified polynucleotides for the production of secreted proteins | Chemistry; Metallurgy | 39 | Active |
| US10703789B2 | Modified polynucleotides for the production of secreted proteins | Chemistry; Metallurgy | 34 | Active |
| US10772975B2 | Modified Polynucleotides for the production of biologics and proteins associated with human disease | Emerging Cross-Sectional Technologies | 34 | Active |
| US10583203B2 | In vivo production of proteins | Emerging Cross-Sectional Technologies | 28 | Active |
| US10493167B2 | In vivo production of proteins | Emerging Cross-Sectional Technologies | 25 | Active |
| US9814760B2 | Modified polynucleotides for the production of biologics and proteins associated with human disease | Emerging Cross-Sectional Technologies | 14 | Active |
| US10463751B2 | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins | Emerging Cross-Sectional Technologies | 12 | Active |
| US10501513B2 | Modified polynucleotides for the production of oncology-related proteins and peptides | Chemistry; Metallurgy | 10 | Active |
| US10501512B2 | Modified polynucleotides | Chemistry; Metallurgy | 8 | Active |
| US10385106B2 | Modified polynucleotides for the production of secreted proteins | Chemistry; Metallurgy | 7 | Active |
| US9827332B2 | Modified polynucleotides for the production of proteins | Chemistry; Metallurgy | 6 | Active |
| US9782462B2 | Modified polynucleotides for the production of proteins associated with human disease | Chemistry; Metallurgy | 6 | Active |
| US9828416B2 | Modified polynucleotides for the production of secreted proteins | Chemistry; Metallurgy | 2 | Active |
| US11564998B2 | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins | Emerging Cross-Sectional Technologies | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.